These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [Monoclonal antibodies against fibrinogen and fibrin and against their proteolytic degradation products]. Dyr JE; Cajthamlová H; Suttnar J Cas Lek Cesk; 1990 Oct; 129(43):1349-51. PubMed ID: 2249231 [TBL] [Abstract][Full Text] [Related]
3. Measurement of crosslinked fibrin degradation products - an immunoassay using monoclonal antibodies. Elms MJ; Bunce IH; Bundesen PG; Rylatt DB; Webber AJ; Masci PP; Whitaker AN Thromb Haemost; 1983 Aug; 50(2):591-4. PubMed ID: 6356456 [TBL] [Abstract][Full Text] [Related]
4. [A group of monoclonal antibodies against human fibrinogen and its fragments]. Wu XW Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1988 Aug; 10(4):288-90. PubMed ID: 2976318 [No Abstract] [Full Text] [Related]
5. Markers of fibrinogen derivatives used in clinical investigation. Soria J; Soria C; Mirshahi M; Samama MM Semin Thromb Hemost; 1985 Apr; 11(2):129-32. PubMed ID: 2412296 [No Abstract] [Full Text] [Related]
6. The monoclonal antibody that recognizes an epitope in the C-terminal region of the fibrinogen alpha-chain reacts with soluble fibrin and fibrin monomer generated by thrombin but not with those formed as plasmin degradation products. Suzuki A; Ebinuma H; Matsuo M; Miyazaki O; Yago H Thromb Res; 2007; 121(3):377-85. PubMed ID: 17561232 [TBL] [Abstract][Full Text] [Related]
7. Monoclonal antibodies to fibrinogen-fibrin degradation products which contain D-domain. Matsumoto T; Nishijima Y; Teramura Y; Fujino K; Hibino M; Hirata M Thromb Res; 1985 May; 38(3):297-302. PubMed ID: 2410999 [No Abstract] [Full Text] [Related]
8. Immunohistochemical characterization of fibrin(ogen)-related antigens in human tissues using monoclonal antibodies. Bini A; Mesa-Tejada R; Fenoglio JJ; Kudryk B; Kaplan KL Lab Invest; 1989 Jun; 60(6):814-21. PubMed ID: 2659890 [TBL] [Abstract][Full Text] [Related]
9. A monoclonal antibody-based enzyme immunoassay for fibrin degradation products in plasma. Koppert PW; Hoegee-de Nobel E; Nieuwenhuizen W Thromb Haemost; 1988 Apr; 59(2):310-5. PubMed ID: 3133813 [TBL] [Abstract][Full Text] [Related]
10. [Clinical significance of a new fibrinogen/fibrin degradation products(FDP) test using plasma samples for the diagnosis of fibrinogenolysis and fibrinolysis]. Imoto K; Yasumuro Y; Taki M; Suzuki N; Tanabe H; Ichikawa Y Rinsho Byori; 2001 Mar; 49(3):283-9. PubMed ID: 11307330 [TBL] [Abstract][Full Text] [Related]
11. Validation, calibration, and specificity of quantitative D-dimer assays. Dempfle CE Semin Vasc Med; 2005 Nov; 5(4):315-20. PubMed ID: 16302152 [TBL] [Abstract][Full Text] [Related]
12. Immunoreactivity of cross-linked fibrin derivatives (D-dimer) and monoclonal antibodies. Rylatt D; Bundesen P Blood Coagul Fibrinolysis; 1996 Apr; 7(3):365. PubMed ID: 8735147 [No Abstract] [Full Text] [Related]
13. Monoclonal antibodies from rats immunized with fragment D of human fibrinogen. Kennel SJ; Chen JP; Lankford PK; Foote LJ Thromb Res; 1981 May; 22(3):309-20. PubMed ID: 7302901 [No Abstract] [Full Text] [Related]
14. Binding of a new monoclonal antibody against N-terminal heptapeptide of fibrin alpha-chain to fibrin polymerization site 'A': effects of fibrinogen and fibrinogen derivatives, and pretreatment of samples with NaSCN. Dempfle CE; Dollman M; Lill H; Puzzovio D; Dessauer A; Heene DL Blood Coagul Fibrinolysis; 1993 Feb; 4(1):79-86. PubMed ID: 8457657 [TBL] [Abstract][Full Text] [Related]
15. Novel monoclonal antibody that recognizes new neoantigenic determinant of D-dimer. Doh HJ; Song KS; Kang MS; Kim DS; Kim KA; Kang J; Jang Y; Chung KH Thromb Res; 2006; 118(3):353-60. PubMed ID: 16139872 [TBL] [Abstract][Full Text] [Related]
16. Plasma cross-linked fibrin degradation product (XLFbDP) assays in an in vivo model of fibrinolysis. Rowbotham BJ; Whitaker AN; Masci PP Blood Coagul Fibrinolysis; 1990 Dec; 1(6):653-61. PubMed ID: 2133245 [TBL] [Abstract][Full Text] [Related]
17. Fibrin detected in plasma of patients with disseminated intravascular coagulation by fibrin-specific antibodies consists primarily of high molecular weight factor XIIIa-crosslinked and plasmin-modified complexes partially containing fibrinopeptide A. Pfitzner SA; Dempfle CE; Matsuda M; Heene DL Thromb Haemost; 1997 Sep; 78(3):1069-78. PubMed ID: 9308756 [TBL] [Abstract][Full Text] [Related]